Jeremy Cheng

Massachusetts Institute of Technology

Papers

1

Total Citations

2

H-Index

1

About

Jeremy Cheng’s research focuses on the intersection of radiation oncology and advanced medical physics, particularly in the realm of stereotactic body radiotherapy (SBRT) for prostate cancer. His most cited work, a 2016 study, pioneered a novel dosimetric validation technique for robotic prostate SBRT with simultaneous integrated dose escalation to dominant intraprostatic lesions. By employing a magnetic resonance–based 3D-printed prostate model within an anthropomorphic pelvis phantom, Cheng demonstrated a method to precisely target aggressive tumor subregions while sparing surrounding healthy tissue—a critical advancement in personalized cancer treatment. Though his citation count remains modest, this foundational work has implications for improving clinical outcomes in high-risk prostate cancer patients. Cheng’s contributions exemplify the meticulous translational research needed to bridge cutting-edge imaging and 3D-printing technologies with practical radiotherapy delivery, offering a roadmap for future studies in dose escalation and organ-at-risk sparing. His approach underscores the growing importance of patient-specific phantoms in validating complex treatment plans, making him a notable figure in the evolving field of precision radiation oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Dosimetric Validation of Robotic Prostate SBRT With Simultaneous Integrated Dose Escalation to Dominant Intraprostatic Lesion Using a Magnetic Resonance–Based 3D-Printed Prostate Model in an Anthropomorphic Pelvis Phantom
2 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Massachusetts Institute of Technology

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago